drug
sotalol hydrochloride
Marketedupdated 4mo agoby Covis Pharmaceuticals Inc (Inactive)
Approvedcommunity read0 votes
indications
investigational
Atrial Fibrillation
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 14, 2028
~2.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (11)
- Aug 21, 2039method-of-use (U-3549)US 11583216
- Apr 5, 2039method-of-use (U-3125)US 10799138
- Aug 14, 2038method-of-use (U-3547)US 10512620
- Aug 14, 2038method-of-use (U-2769)US 11696902
- Aug 14, 2038method-of-use (U-2769)US 12390431
- Aug 31, 2035formulationUS 9724297
- Nov 19, 2034method-of-use (U-2494)US 11850222
- Apr 1, 2034formulationUS 10206895
- Apr 1, 2034formulationUS 11013703
- Apr 1, 2034method-of-use (U-2494)US 12290495
- Aug 14, 2028method-of-use (U-2769)US 124031092.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that